- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/06 - BenzimidazolesHydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
Patent holdings for IPC class C07D 235/06
Total number of patents in this class: 461
10-year publication summary
|
39
|
26
|
29
|
28
|
18
|
23
|
19
|
24
|
22
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Array BioPharma Inc. | 498 |
25 |
| AstraZeneca AB | 2892 |
15 |
| Probiodrug AG | 62 |
10 |
| LG Chem, Ltd. | 17635 |
9 |
| F. Hoffmann-La Roche AG | 7947 |
6 |
| BioAge Labs, Inc. | 40 |
6 |
| Vivoryon Therapeutics N.V. | 44 |
6 |
| Allergan, Inc. | 2347 |
5 |
| Agios Pharmaceuticals, Inc | 216 |
5 |
| Biosplice Therapeutics, Inc. | 171 |
5 |
| Novartis AG | 10744 |
4 |
| Bayer Pharma AG | 1053 |
4 |
| Abbvie Inc. | 1800 |
4 |
| Mayo Foundation for Medical Education and Research | 3222 |
4 |
| Nippon Shinyaku Co., Ltd. | 322 |
4 |
| University of Tennessee Research Foundation | 753 |
4 |
| The Wistar Institute of Anatomy and Biology | 453 |
4 |
| Regenacy Pharmaceuticals, LLC | 26 |
4 |
| Tempest Therapeutics, Inc. | 25 |
4 |
| Vivoryon Therapeutics AG | 20 |
4 |
| Other owners | 329 |